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Executive Summary 
 
External-field mediated transdermal drug delivery is a new alternative to oral delivery 
and hypodermic injections. This method allows patients to receive treatments via a drug-infused 
patch applied to the skin and offers continuous release of drug for up to a week. It is also 
relatively inexpensive compared to regular treatments. In our design, ultrasound and an applied 
electric field are used to increase the rate of drug diffusion and propagation from the patch into 
and across the skin. Previous research has shown that the application of ultrasound results in 
higher rates of transdermal transport by increasing the permeability of the stratum corneum. 
This permeabilization can be so great that the patch or drug reservoir itself becomes the most 
significant barrier to the overall transdermal drug transport. An applied voltage has been shown 
to be capable of creating a driving force for transport that counteracts this effect.  
 
In this project, we combined the effects of applied voltage and ultrasound in order to 
model the transdermal transport of insulin from a methyl-cellulose hydrogel through the skin. 
Because the typical drug-delivery patch is circular, we modeled the problem in a 2D-
axisymmetric geometry. Next, we determined the effects of intensity and voltage on the average 
insulin concentration in the skin. To do this, we conducted a sensitivity analysis by varying the 
applied voltages and intensities on the hydrogel and calculating the corresponding average 
insulin concentration in the skin at a specific time point. Finally, by using an objective function, 
we maximized the flux of insulin through the skin while minimizing patient discomfort.    
 
The iontophoretic and sonophoretic aspects of our model were validated individually 
through comparison with experimental data. We found that voltage and intensity from 
ultrasound combined provide the greatest increase in insulin transport through the skin.  An 
intensity of 1 kW/m2 in conjunction with an applied voltage of -2 V resulted in the optimum 
insulin flux through the skin while maintaining minimal patient discomfort. The optimal 
intensity was found to be at the lower end of the range of experimentally and clinically utilized 
values. This suggests that higher intensities may contribute unnecessary heating without 
significantly enhancing insulin transport through the skin. Based on our optimization results, it 
can be seen that transdermal delivery of insulin through the skin is efficient when coupled with 
ultrasound and applied voltage. 
 
Our results show that with the application of sonophoresis and iontophoresis, insulin is 
effectively able to diffuse through the skin into the bloodstream. Our optimization also shows 
that this type of insulin delivery would cause minimal discomfort or skin damage. This suggests 
that transdermal delivery of insulin through the skin is a promising treatment for patients with 
diabetes.  
 
 
Introduction 
  
Diabetes is the 7th largest cause of death in the United States, leading to lower life 
expectancy, heart disease, and kidney failure [1]. Patients with diabetes experience high medical 
care costs due to the regular insulin injections required to control glucose levels. In the United 
States, almost 23.6 million people are currently diagnosed with diabetes [2]. There are two 
types of diabetes: Type I and Type II diabetes. In Type I diabetes, the patient’s pancreas is 
unable to produce the insulin that is needed to break down glucose into energy. In Type II 
diabetes, the patient’s pancreas either does not produce enough insulin or their body cells do not 
recognize the insulin that is produced. Diabetics who can not produce any or enough insulin 
must find another way to maintain healthy blood-insulin levels.  
 
Currently, the most common ways to increase the level of insulin in the bloodstream are 
through insulin injection or use of an insulin pump. However, both of these methods require 
insertion of a needle or cannulas. These methods can be painful and cause scarring.  
 
 Transdermal drug delivery is an alternative to hypodermic injections and pumps. The 
first transdermal delivery system was applied to motion sickness and was approved in the 
United States in 1979 [3]. Transdermal delivery has many advantages over hypodermic 
injections including less pain, reduction of dangerous medical waste, avoidance of certain 
disease transmission pathways, and low cost. However, there a limited number of drugs that can 
be effectively delivered transdermally because of the extremely low permeability of the 
epidermis. In particular, drugs that have high molecular weight or are strongly hydrophobic are 
difficult to apply transdermally [3]. Insulin is one of these drugs, with a molecular weight of 
5808 Da. 
 
In this study, insulin is transdermally delivered through skin via a hydrogel patch. 
However, since the high molecular weight of insulin inhibits it from easily passing through the 
skin, other agents are required in addition to the patch to increase the rate of insulin transport 
across the skin.  
 
One of these agents is ultrasound transmission. Ultrasound creates cavitation- the 
formation, oscillation and collapse of bubbles- which generates shock waves and liquid 
microjets directed at the stratum corneum. This breaks apart the lipid structure of the stratum 
corneum and increases skin permeability, allowing more insulin to enter through the skin. 
Despite this benefit, penetration of ultrasound energy directly through the skin can be painful 
and dangerous. An ultrasound coupling medium such as a methyl-cellulose hydrogel can be 
used to mitigate the harmful effects of ultrasound. Unfortunately, this coupling medium can 
impede the diffusion of insulin through the skin. Voltage can be applied along with ultrasound 
and a coupling medium to counteract this hindrance. Experimental results have shown that with 
the addition of a voltage potential, the diffusivity of insulin through the skin increases more so 
than when ultrasound energy was applied alone [2]. 
 
Problem Statement 
 
Using COMSOL, we modeled the diffusion of insulin into the skin from a methyl-
cellulose hydrogel reservoir in response to the application of low-frequency ultrasound and a 
voltage to the surface of the skin.  
 
Design Objectives 
 
Based on our desire to maximize insulin flux while minimizing patient discomfort and skin 
tissue damage, we decided on three design objectives for our study, which are listed below.  
  
1. Develop an accurate model of transdermal insulin delivery that combines the effects of 
applied voltage and ultrasound 
2. Conduct sensitivity analysis to determine the relative effect of applied voltage and 
ultrasound on insulin diffusion rate 
3. Optimize the flux of insulin while minimizing patient discomfort using an objective 
function 
 
Governing Equations 
 
The governing equations for our model are discussed in detail below. The various terms 
and equations used to relate these equations to one another are included in Appendix A.  
 
Mass Species Conservation with Nernst-Planck  
Diffusion of insulin is modeled by calculating the concentration throughout the hydrogel and 
skin over time. The Nernst-Planck equation [Equation 1]  is used because the species of interest, 
insulin, is a charged molecule. 
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డ௧ ൅ ߘ ∘ ሺെܦߘܿ െ ݖݑ௠ܨܿ ⊽ ܸሻ 	ൌ 0       [Equation 1] 
 
Theെܦߘܿ term describes diffusion within the materials and the ݖݑ௠ܨܿ ⊽ ܸterm describes the 
bulk flow effect caused by the applied voltage. Diffusivity is a function of both temperature and 
ultrasound frequency, as described by the equations in Appendix B.  
 
Poisson Voltage Equation 
The Poisson equation [Equation 2] is used to calculate the voltage throughout the material. 
 
ܬ	 ൌ 	െሺߪ ൅	ߝ଴ߝ௥ሻܧ        [Equation 2] 
 
The calculated voltage depends on the applied voltage boundary condition, the electrical 
conductivity, vacuum permittivity, and relative permittivity. The electrical conductivity varies 
with temperature. The empirically derived equation describing this dependence is given in 
Appendix B for each material. 
 
Helmholtz Equation 
The Helmholtz equation [Equation 3] characterizes the pressure waves caused by ultrasound. 
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As can be seen in Equation 3, the pressure profile depends on the angular frequency 
of the ultrasound, ⍵,  the complex density,  ⍴c, and complex speed of sound in the medium 
cc. 
 
Heat Transfer Equation: 
The heat transfer equation [Equation 4] is used to describe heat transfer within the materials. 
 
⍴ܿ௣ ఋ்ఋ௧ ൌ ߘ ∘ ሺ݇ߘܶሻ ൅ ܳ        [Equation 4] 
 
Q, the heat generation term, is a function of ultrasound intensity and pressure as well as applied 
voltage. The exact formula is given in Appendix B. Metabolic heat generation is negligible 
compared to heat generated by ultrasound and the applied voltage, and so has been ignored. The 
thermal conductivity of each of the materials is dependent on temperature, with the general 
relationship being higher conductivity at higher temperature. The precise equations describing 
the thermal conductivity of each material have been obtained empirically and are given in 
Appendix B. 
 
Figure 1 below shows the relationships between the terms in our model. 
 
Figure 1. Interconnectivity of physics implemented in the model. Only three terms, 
ultrasound frequency, surface intensity and applied voltage are entirely independent. 
Terms such as temperature and voltage have many connections and are therefore 
expected to exhibit strong influence on the model as a whole.  
 
As can be seen above, the terms associated with the Helmholtz equation are not dependent on 
the results of any of the other equations. The heat equation relies on terms calculated in the 
Helmholtz physics and the Poisson equation, which itself is dependent on the results of the heat 
equation. For this reason, the heat equation and Poisson equation are solved concurrently in our 
model. The Nernst-Planck equation requires variables calculated by the other equations but does 
not feed any values to them.  
 
Initial Conditions 
 
The initial concentration of insulin is 21.22 mol/m3 in the hydrogel and zero in both the dermis 
and epidermis. This value was calculated such that the total amount of insulin in the patch meets 
an average patient’s daily requirement and would be enough for several days [5]. The voltage 
and pressure are initially zero in all domains. Temperature in the hydrogel is set to room 
temperature, 298.15 K, and in the dermis and epidermis it begins at average body temperature, 
310.15 K. 
 
 
 
Design Schematic  
 
For the purposes of the model, the skin is assumed to be semi-infinite in both the radial 
and axial directions. As shown below in Figure 2, our model is split into three distinct parts: the 
hydrogel, epidermis and dermis. Ultrasound and voltage are applied to the top surface of the 
circular patch, which has a radius of 2.5 cm and a thickness of 2.5 mm.  
. 
 
*Not to scale 
Figure 2. Schematic of 2D axisymmetric geometry showing the insulin infused hydrogel, 
epidermis, and dermis layer with dimensions and boundary condition labels. The values 
for boundary conditions are shown in Table 2. 
 
There are six boundaries in our model. Each boundary has a specific concentration, voltage, 
temperature, and ultrasound condition. These are all described below. Specific conditions 
corresponding to each boundary and physics can be found in Table 1 of Appendix B.  
 
Concentration Boundary Conditions 
At the skin and hydrogel surfaces (1, 2, and 3) there is assumed to be no loss of insulin by 
evaporation or other mechanisms, so a zero flux boundary condition is applied. Because the skin 
domain has been assumed semi-infinite, no insulin is expected to reach the far right boundary, 
4, so concentration is set to zero there at all times. Similarly, the concentration of insulin at 
boundary 5 is assumed to remain zero as it is expected that all of the insulin that reaches that 
boundary will be carried away in the bloodstream. The axisymmetry of our model means that 
there is no flux of insulin across boundary 6.  
 
 
Voltage Boundary Conditions 
A constant A.C. voltage is applied to the top surface of the patch, so there is a constant voltage 
condition on boundary 1. The same semi-infinite and symmetry explanations apply to the 
voltage conditions on boundaries 4 and 5. At the skin surface and axis of symmetry (2, 3, and 6) 
there is no voltage flux. 
 
Temperature Boundary Conditions 
Boundaries 1, 2, and 3 are in contact with air, and so a convective boundary condition is applied 
to them. On boundary 4 and 5, the semi-infinite assumption means that temperature change 
never propagates to these boundaries, and they thus remain at body temperature. The 
axisymmetry of the model once again means that there is no flux across boundary 6. 
 
Ultrasound Boundary Conditions  
At the top of the hydrogel (1) there is a constant pressure flux caused by the applied ultrasound. 
There is no pressure flux at boundaries 2 and 3, as the pressure wave is assumed to be 
perpendicular or at boundary 4 due to the semi-infinite assumption, or at boundary 6 because of 
axial symmetry. At boundary 5 there is a no pressure flux condition in combination with an 
absorption condition which limits inward wave propagation as well as reflection at the boundary 
from inside. This ensures a physical solution. 
 
Results 
 
Preliminary Results 
 
The figure below (Figure 3) shows the diffusion of insulin when there is no applied voltage or 
ultrasound. After an hour, the diffusion profile has only progressed to the epidermis. 
 
 
0 V, 0 I, 1 hr 
Figure 3. Zero Voltage Concentration Plot Showing the Concentration Gradient Through 
Dermis and Epidermis 
 
Because the diffusivity in the epidermis is 2-3 orders of magnitude lower than in the other 
regions, it serves as an obstacle to drug diffusion. This is why the concentration gradient is 
largest in the epidermis and near negligible in the other regions, demonstrating the need for both 
ultrasound and voltage applied across the surface. 
 
Model Validation 
 
Paired iontophoretic and sonophoretic transdermal drug delivery studies do not exist. For this 
reason, it was necessary to validate these aspects of our model individually. To validate the 
sonophoretic aspect of our model, our model was changed to match the specification of an 
experiment Ultrasound Mediated Transdermal Drug Delivery [27]. This study involved 
studying the transdermal insuling flux of insulin across a rat’s epidermal membrane using a 
ultrasound applying transducer above a Franz diffusion cell. Conceptually, a Franz diffusion 
cell is essentially a beaker with a membrane stretched taut across the top with a reservoir of 
solution above the membrane. Solution that has diffused through can be tested in the beaker to 
determine the amount that has diffused through. Changes implemented include: making the 
geometry the same rectangular shape as the cell-epidermis system and changing the lower 
constant temperature boundary to convective heat flux.  
 
 
Figure 5. Ultrasound Mediated Transdermal Drug Delivery Validation 
Calculating the total Insulin that has diffused through suggests that our model is validated by 
the study as the results are very similar. This shows that our implementation of ultrasound was 
successful in being a good model of the physics at hand.  
 To validate iontophoresis, the model was compared to a study entitled Transdermal 
Iontophoresis of Insulin IV: Effect of Chemical Enhancers Validation [26]. The protocol for the 
study was exactly the same as the previous case: measuring drug permeated across an epidermal 
membrane in a Franz diffusion cell except that an anode and cathode were present to develop a 
Voltage across the membrane instead of the ultrasound transducer. 
 
Figure 6. Transdermal Iontophoresis of Insulin IV: Effect of Chemical Enhancers 
Validation 
Our study of the passive impact without voltage was very successful and results are near 
identical. The results for voltage applied were not so successful. Although they are within the 
same order of magnitude and the actual difference between them is not great, the voltage results 
vary because the study used did not state a voltage applied, rather a current density applied. 
Thus to find voltage applied, Ohm’s law was used which is not entirely accurate for skin due to 
non-linearities, and values for resistance were highly variable in the literature ranging from 100 
ohms to 100 megaohms. Voltage applied could be arbitrarily changed to match our results to the 
results of the study, but this would not be useful in validation as the validation step is important 
in checking and confirming your results, not a way to reverse-engineer parameters.  
 Sensitivity Analysis 
 
In order to determine the necessity of obtaining accurate values for certain parameters, a 
sensitivity analysis was conducted. Beginning with experimental measurements of specific 
heats and thermal conductivities of hydrogel and the epidermis, we increased and decreased the 
values by 10% . We then calculated the average concentration in the skin based on these 
property values, and the bar graph (Figure 9) shows the effects of these parameters on the 
solution. 
 
 
Figure 9. Variation in average concentration of insulin in skin at t = 330 minutes when the 
properties of hydrogel and epidermis  are varied within + 10% of their original value.  
 
According to the above graph, the effects of varying the specific heats and thermal 
conductivities of the hydrogel and the epidermis show no significant effect on the average 
concentration of insulin in the skin. Based on this, we can assume that even if the experimental 
values we obtained for these parameters are not exact, this error would not significantly affect 
our solution.  
 
In order to garner a fuller understanding of the effects of Iontophoresis and sonophoresis on 
transdermal drug transport we sought to run a sensitivity analysis on voltage and ultrasound. We 
were specifically interested in determining if the improvement in drug transport evidenced by 
the combination of these methods was predominantly due to one effect or the other.  
 
In addition, an analysis of solution sensitivity to changes in applied voltage will allow us to 
check the accuracy of our model. The greater the applied voltage, the faster should be the rate of 
insulin transport, and the further the depth of its penetration at steady-state. 
 
 
 
Figure 7. Average insulin concentration in the epidermis and dermis over for a range of 
voltages over time. It can be seen that the result is more heavily influenced by voltage 
changes at smaller voltages. 
 
The fact that average concentration of insulin in the skin at a certain time point increases with 
increasing voltage shows that our model is consistent with previous research which has stated 
that increasing voltage can drive a charged molecule more quickly and thus that higher voltage 
will lead to faster transport.   
 
Below (Figure 8), we show the dependence of the average insulin concentration in the skin on 
the intensity of ultrasound. Specifically, for insulin, enhanced subcutaneous delivery has been 
demonstrated with ultrasound over an intensity range of 0 - 8 kW/m2. Therefore, we conducted 
our sensitivity analysis for these range of values. 
 
Figure 8. Average insulin concentration at the skin over for a range of surface intensities 
over time. It can be seen that at higher surface intensities, insulin passes through the skin 
more quickly. 
 
Figure 8 shows that as the intensity of ultrasound increases, the concentration of insulin 
transported from the hydrogel into the skin increases.  
 
Since both plots above show a dependence of the rate of insulin transport on the variable in 
question (voltage or intensity), it is clear that the optimal result will not be reached by 
considering either alone. 
 
Optimization 
 
I.  Overview 
Because our aim was to increase drug flux without causing the patient undue discomfort, the 
objective function we used to evaluate the effectiveness of each parameter set is described 
qualitatively as follows: The objective function value increases with greater flux at hydrogel-
epidermis boundary (average over study time). It decreases with increasing CEM43 within an 
acceptable range, becoming zero if it exceeds the acceptable threshold. Finally, the function 
value decreases proportionally to some yet to be determined measure of pain due to voltage. 
The function was optimized by maximizing its value over a range of applied AC voltages and 
ultrasound intensities. 
 
II.  Flux Term 
The motivation for introducing ultrasound to transdermal drug-delivery processes is to increase 
drug delivery rate. When used in conjunction with a coupling medium, however, insulin 
diffusion through the hydrogel becomes the limiting factor, rather than diffusion into and across 
the stratum corneum (outermost layer of the epidermis). To combat this, an AC voltage is 
applied to facilitate diffusion through the hydrogel. Therefore, the overall goal is to increase the 
rate of drug delivery, with the primary concern being not diffusion through the stratum corneum 
and epidermis, as in traditional delivery methods, but out of the hydrogel. For this reason, flux 
at the hydrogel-epidermis boundary (FHE) will be used as a measure of the success of a given 
setup.  
 
III. Temperature Term 
In order to quantify the effects of temperature rise, we will use CEM43, or cumulative 
equivalent minutes at 43 C. Though typically used as a measure of cell death, with a lower 
threshold it can be applied to our problem to describe skin damage and discomfort. The MRI + 
EUREKA research consortium organized a workshop for discussion of thermal dose threshold 
models. One of the conclusions was that “9 CEM43 seems an acceptable thermal dose threshold 
for most patients.” [16]. For this reason, the threshold we will use is 9 CEM43.  
CEM43 = ׬ ݐܴሺସଷି்ሻ݀ݐ௧଴  
R at T<43 = 0.25; R at T>43 = 0.5   
T = average temperature during time period 
 
IV.      Objective Function and Results 
The equation for the objective function, shown below, gives the objective function value as a 
difference between a scaled measurement of the average flux of insulin over the first hour and 
the CEM43 over that hour. 
 
O.F.V. = 10^6*Average Flux - CEM43 
 
The table below shows the objective function value for each set of parameters over which the 
model was optimized. Red X’s represent parameters that cause excessive heating (CEM43 > 9).  
 
 -1 V -2 V -3 V -4 V -5 V -6 V -7 V -8 V 
1 
kW/m2 
16.82 20.35 20.20 18.90 X X X X 
2 
kW/m2 
16.79 18.91 16.42 X X X X X 
3 
kW/m2 
10.92 X X X X X X X 
4 
kW/m2 
X X X X X X X X 
5 
kW/m2 
X X X X X X X X 
6 
kW/m2 
X X X X X X X X 
7 X X X X X X X X 
kW/m2 
8 
kW/m2 
X X X X X X X X 
Table 1. Optimization parameters and results of objective function. The prevalence of X’s 
signifies that many experimentally used sets of parameters would be unlikely to be 
popular in clinical treatments as they are likely to cause patient discomfort.  
 
The optimum parameters, as apparent above, are an applied voltage of -2 V and an ultrasound 
intensity of 1kW/m2. These parameters give an average insulin flux of 2.05*10-5 mol/m2s, 
which corresponds to 1.45*10-4 moles of insulin transported across the epidermis in the one 
hour period. As can be seen above, there are only eight sets of parameters that do not overheat 
the model. This is more reasonable than it may seem because the challenge in transdermal drug 
delivery is not overcoming the diffusion barriers, but overcoming them in a way that is 
amenable to patients. 
Discussion 
 
Conclusion 
Based on our optimization results, we can conclude that an applied voltage of - 2 V and an 
ultrasound intensity of 1kW/m2 are ideal for transdermal delivery of insulin. These parameter 
values are at the lower end of the range that have been tested in previous research. This shows 
that a higher ultrasound intensity or applied voltage can cause unnecessary heating to the 
patient’s skin, leading to increased skin damage and discomfort without significantly increasing 
the flux of insulin.  
 
Future Recommendations  
This model could be easily adapted to apply to other drug molecules for which transdermal 
delivery is being considered. In addition, the use of alternate coupling media might allow the 
ultrasound intensity to be increased further without causing pain to the patient. Future study into 
the application of short-duration, higher intensity pulses of voltage and ultrasound might also 
produce interesting results. 
 
 
 
 
 Appendix A. Mesh Convergence 
Mesh Implantation 
Mesh convergence was done for diffusion, where rectangular mesh was applied with a 
mapped distribution. The number of elements in the distribution is 50 and the boundary selected 
was the axis of symmetry. In figure 2 mapped distribution is shown in different layers of the 
model, with the epidermis having the most dense distribution.  
In the Helmholtz portion, a free triangular mesh was used with the maximum element 
sizeଵହହ଴ሺ௠/௦ሻ௙ . As shown in figure 3, the free triangular mesh is most concentrated at the 
epidermis and the top of dermis layer.  
 We varied the values for maximum element size (max_e), minimum element size 
(min_e), maximum element growth rate (growR), resolution of curvature (ResCurv), and 
resolution of narrow regions (ResNar). We decided to use the preset “Extremely fine” mesh, for 
which the values are  0.001 for max_e, 2e-6 for min_e, 1.1 for growR, 0.2 for ResCurv and 1 
for ResNar. 
 
Figure 2. Plot with rectangular mesh for Nernst-Planck, Heating, and Voltage. 
 
Figure 3. Plot with triangular mesh for Ultrasound. 
 
Mesh Convergence 
 
 Mesh convergence was performed through a parametric sweep for the diffusion model, 
where we input the number of elements to be a global parameter and named it “element”. After 
inputting the values for “element,” we created a parametric sweep which ran through the 
elements of 1, 4, 8, 12, 25, 50, and 100. When the computing process was complete, we plotted 
a point graph, resulting in the plot shown in figure 14. As the parameter “element” increases, 
the change between successive concentrations profiles decreases.  
 
Figure 14. Mesh convergence for concentration at different times as shown with different 
numbers of elements. 
  
 By plotting the average concentration of the insulin in the skin over a variety of mesh 
sizes we were able to determine the approximate fineness of mesh that is needed. As the number 
of elements increased, the average concentration of insulin converges to a value. The mesh 
convergence was done at 3600s, where the curve converges at approximately 8000 elements as 
shown in figure 15. This showed the minimum mesh required in our model is about 8000 
elements, and by using a mesh with 8000 elements or more we are not introducing significant 
discretization error to our model. We refrain from using a mesh much finer than 8000 elements 
in order to reduce the computing time of our model. 
 
Figure 15. Mesh convergence for concentration at time = 3600 s with varied number of 
elements. 
Appendix B. Model Design 
 
Boundary Conditions 
 Boundary Nernst-Planck Poisson Heat Equation Helmholtz 
1 Fluxc = 0 V = VS FluxT = h(T-Tinf) FluxP =-2πf(I/ρ/c)½  
Boundary absorption=0 
2 Fluxc = 0 FluxV = 0 FluxT = h(T-Tinf) FluxP = 0 
3 Fluxc = 0 FluxV = 0 FluxT = h(T-Tinf) FluxP = 0 
4 Fluxc = 0 V = 0 T = Tbody FluxP = 0 
5 c  = 0 V = 0 T = Tbody FluxP = 0, 
 Boundary absorption=i*k/rho_c 
6 c  = 0 FluxV = 0 FluxT = 0 FluxP = 0 
 
Other Terms  
Name Equation 
Acoustic Heat Source  ܳ ൌ 2ߙ஺஻ௌܫ ൅ ߘܬ 
Temperature Dependence of Human Tissue 
Thermal Conductivity  
k = 0.4692 + 0.0012*(T-273.15) 
Temperature Dependence of Hydrogel Thermal 
Conductivity  
k = k298.15*(1+0.0015*(T-298.15)) 
Skin Diffusivity Temperature Dependence  D = D310.15*(1 + 0.152778*(T-310.15)) 
Hydrogel Diffusivity Temperature Dependence D = D298.15(1 + 0.015*(T-298.15)) 
Tissue (liver) Electrical Conductivity 
Temperature Dependence  
σ = 0.0078*T - 1.9827 
Hydrogel Electrical Conductivity Temperature 
Dependence 
σ = 1.3*(1.02)abs(T-298.15) 
Effective Diffusivity for Epidermis Deff = Kpus(Lgel+h) 
Permeability Coefficient in the Presence of 
Ultrasound 
Kpus=194Km(fD∞+(1-f)D0) 
Permeant Diffusion Coefficient D0=KPP/(194Km) 
Partition Coefficient Km=KO|W.75 
Fraction of area of unordered lipid bilayer f =.15663/(R/R0)-.14269 
Linear Regression of Resistance Reduction 
against Ultrasound Duty and Intensity (Duty is 
1 in our model) 
R/R0=.84318-.08411(Intensity) 
[11] [12] [13] [17] [18] [19] [21] 
 
Terms for Ultrasound Wave 
Intensity of the ultrasonic wave ܫ ൌ ටܫ௭ଶ ൅ ܫఝଶ ൅ ܫ௥ଶ 
Wave intensity in the axial direction ܫ௭ ൌ 0.5 ∗ ሺ݌ ∙ ݒ௭ሻ 
Wave intensity in the angular direction ܫఝ ൌ 0.5 ∗ ሺ݌ ∙ ݒఝሻ 
Wave intensity in the radial direction ܫ௥ ൌ 0.5 ∗ ሺ݌ ∙ ݒ௥ሻ 
Velocity in axial direction 
ݒ௭ ൌ െ
݀݌
݀ݖ
ሺߩ௖ ∗ ݅ ∗ ߱ሻ  
Velocity in angular direction 
ݒఝ ൌ െ
݀݌
݀߮
ሺߩ௖ ∗ ݅ ∗ ߱ሻ  
Velocity in radial direction 
ݒ௥ ൌ െ
݀݌
݀ݎ
ሺߩ௖ ∗ ݅ ∗ ߱ሻ  
Complex density  ߩ௖ ൌ ߩ௧ ∗ ൬ܿ଴ܿ௖൰
ଶ
 
Complex speed of sound ܿ௖ ൌ ߱݇  
Wave moves in k direction ݇ ൌ ൬߱ܿ଴൰ െ ሺ݅ ∗ ߙሻ 
[25] 
 
 
 
 
Input Parameters  
Epidermal Thermal Conductivity (kepidermal) 0.59 W/mK 
Dermal Thermal Conductivity (kdermal) 0.4 W/mK 
Hydrogel Thermal Conductivity  0.6096 W/mK 
Epidermal Density (ρepidermal)  1044 kg/݉ଷ 
Dermal Density (ρdermal) 1048 kg/݉ଷ 
Hydrogel Density (ρhydrogel) 999.997 kg/݉ଷ 
Epidermal Specific Heat (Cp,epidermal) 3710 J/kgK 
Dermal Specific Heat (Cp,dermal) 3650 J/kgK 
Diffusivity, dermis (Ddermis) 5.8e-11 m2/s 
Diffusivity, epidermis (Depidermis) 1.58e-13 m2/s 
Diffusivity, hydrogel (Dhydrogel) 1e-10 m2/s 
Diffusivity, voltage (Dvoltage) 3.6e-3 m2/s 
Alpha, hydrogel  0.0251 /m 
Alpha, skin 8.55 /m 
Hydrogel Electrical Conductivity  1.3 S/m  
Dermis Electrical Conductivity 0.44 S/m 
Epidermis Electrical Conductivity 0.44 S/m 
Permeant Diffusion Coefficent in a 
Disordered Bilayer (D∞)  
1.17422 e-6 cm2/sec 
Octanal/Water Partition Coefficient of Insulin 
(KO|W) 
.017378 
Passive Permeability Coefficient (KPP) 3.25 e-8 cm/sec 
Thickness of Gel (Lgel) .0025 m 
Thickness of Epidermis (h) .000015 m 
Table 3. List of input parameters for our model. Values are given at 310.15 K for skin 
parameters and 298.15 K for hydrogel parameters. [18] [20] 
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